Loss Executives Association

Judge Rules Bristol Myers Must Face $6.7B Lawsuit Over Delayed Cancer Drug

December 2, 2025

A U.S. judge on Monday rejected Bristol Myers Squibb’s bid to dismiss a $6.7 billion lawsuit claiming it cheated shareholders of the former Celgene by delaying federal approval for three drugs, including the cancer treatment Breyanzi, by specified deadlines. While …

Read the full article →

Share:

More Posts

Amazon’s New Order Confirmation Emails Seen Boosting Phishing Risk

When Dan Landau ordered a portable photo printer from Amazon.com Inc., he expected the confirmation email to tell him what was on its way. Instead,

USI Sues 3 Former Producers After They Allegedly Moved Clients to Howden US

USI Insurance Services has sued three former producers, who “reneged on their contractual obligations” in a move to competitor Howden US, the brokerage alleged. According

Los Angeles Faces Days of 100F Heat as Southwest Fire Risk Grows

Los Angeles is bracing for a lengthy heat wave as the weather system that’s cooked Texas expands westward and begins stripping moisture from Southern California’s

Send Us A Message